These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 32804255)

  • 1. Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum.
    Ohm DT; Peterson C; Lobrovich R; Cousins KAQ; Gibbons GS; McMillan CT; Wolk DA; Van Deerlin V; Elman L; Spindler M; Deik A; Siderowf A; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol; 2020 Nov; 140(5):675-693. PubMed ID: 32804255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
    Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locus Coeruleus Degeneration Differs Between Frontotemporal Lobar Degeneration Subtypes.
    Matti N; Javanshiri K; Haglund M; Saenz-Sardá X; Englund E
    J Alzheimers Dis; 2022; 89(2):463-471. PubMed ID: 35871340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
    Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
    Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent Histopathological Networks of Frontotemporal Degeneration Proteinopathy Subytpes.
    Chen M; Ohm DT; Phillips JS; McMillan CT; Capp N; Peterson C; Xie E; Wolk DA; Trojanowski JQ; Lee EB; Gee J; Grossman M; Irwin DJ
    J Neurosci; 2022 May; 42(18):3868-3877. PubMed ID: 35318284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.
    Irwin DJ; Lleó A; Xie SX; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
    Ann Neurol; 2017 Aug; 82(2):247-258. PubMed ID: 28719018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phases of volume loss in patients with known frontotemporal lobar degeneration spectrum pathology.
    Burke SE; Phillips JS; Olm CA; Peterson CS; Cook PA; Gee JC; Lee EB; Trojanowski JQ; Massimo L; Irwin DJ; Grossman M
    Neurobiol Aging; 2022 May; 113():95-107. PubMed ID: 35325815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signature laminar distributions of pathology in frontotemporal lobar degeneration.
    Ohm DT; Cousins KAQ; Xie SX; Peterson C; McMillan CT; Massimo L; Raskovsky K; Wolk DA; Van Deerlin VM; Elman L; Spindler M; Deik A; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol; 2022 Mar; 143(3):363-382. PubMed ID: 34997851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathology.
    Koga S; Zhou X; Murakami A; Fernandez De Castro C; Baker MC; Rademakers R; Dickson DW
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12778. PubMed ID: 34823271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration.
    Cervantes González A; Irwin DJ; Alcolea D; McMillan CT; Chen-Plotkin A; Wolk D; Sirisi S; Dols-Icardo O; Querol-Vilaseca M; Illán-Gala I; Santos-Santos MA; Fortea J; Lee EB; Trojanowski JQ; Grossman M; Lleó A; Belbin O
    Mol Neurodegener; 2022 Apr; 17(1):29. PubMed ID: 35395770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration.
    Giannini LAA; Ohm DT; Rozemuller AJM; Dratch L; Suh E; van Deerlin VM; Trojanowski JQ; Lee EB; van Swieten JC; Grossman M; Seelaar H; Irwin DJ;
    Acta Neuropathol; 2022 Dec; 144(6):1065-1084. PubMed ID: 36066634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.
    Kim EJ; Brown JA; Deng J; Hwang JL; Spina S; Miller ZA; DeMay MG; Valcour V; Karydas A; Ramos EM; Coppola G; Miller BL; Rosen HJ; Seeley WW; Grinberg LT
    J Neurol; 2018 Dec; 265(12):2960-2971. PubMed ID: 30324308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
    Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.
    Geula C; Dunlop SR; Ayala I; Kawles AS; Flanagan ME; Gefen T; Mesulam MM
    J Neurochem; 2021 Sep; 158(6):1394-1411. PubMed ID: 34272732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration.
    Taylor LM; McMillan PJ; Liachko NF; Strovas TJ; Ghetti B; Bird TD; Keene CD; Kraemer BC
    Mol Neurodegener; 2018 Feb; 13(1):7. PubMed ID: 29409526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights.
    Scarioni M; Gami-Patel P; Peeters CFW; de Koning F; Seelaar H; Mol MO; van Swieten JC; ; Rozemuller AJM; Hoozemans JJM; Pijnenburg YAL; Dijkstra AA
    Brain; 2023 Jan; 146(1):307-320. PubMed ID: 35136978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
    Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
    J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers.
    Cousins KAQ; Shaw LM; Chen-Plotkin A; Wolk DA; Van Deerlin VM; Lee EB; McMillan CT; Grossman M; Irwin DJ
    JAMA Neurol; 2022 Nov; 79(11):1155-1164. PubMed ID: 36215050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.
    Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM;
    Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.